Beijing Health Guard Biotechnology (BJSE:920575) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920575 Beijing Health Guard Biotechnology Inc BJSE:920575
47 GF Score
Price ¥5.59
GF Value ¥7.92
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Beijing Health Guard Biotechnology FFO?

FFO (Funds from operations) only applies to REITs.

BJSE:920575
47GF Score
Beijing Health Guard Biotechnology Inc BJSE:920575
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Health Guard Biotechnology (BJSE:920575) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Health Guard Biotechnology stock appears to be undervalued. The current stock price of ¥5.59 is trading 29.4% below its estimated GF Value™ of ¥7.92. GuruFocus considers Beijing Health Guard Biotechnology to be Modestly Undervalued.

Key valuation signals for BJSE:920575:

  • FFO:
  • GF Value™: ¥7.92 vs. price of ¥5.59 (29.4% below fair value)
  • GF Score™: 47/100 with 10 warning signs

No single metric tells the full story. See the BJSE:920575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beijing Health Guard Biotechnology Business Description

Address No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.
47GF Score

Get the complete analysis for BJSE:920575

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.59
Price
¥7.92
GF Value